Predictive Technology Group, Inc. (PRED) Announces Key Patent Issuance by US Patent and Trademark Office for Treating Patients With Genetic Spinal Deformities and Syndromes Life Science Investing
SCYNEXIS Announces Pricing of $22.5 Million Public Offering of Common Stock and Warrants Life Science Investing
RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D Life Science Investing
Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine Clinical Trial Life Science Investing
Zosano Pharma Enrolls First Subject in Pivotal Clinical Trial for ZP-Triptan Patch Program for Treatment of Migraine Life Science Investing
VBI Vaccines to Present at the Virus-Like Particle and Nano-Particle Vaccines Conference Biotech Investing
Sagent Pharmaceuticals Acquires Product Portfolio From Teva Pharmaceutical Industries Ltd. Life Science Investing
Vaxil Receives Positive Response From European Patent Office for the Allowance of the Immunotherapy Orphan Drug Designated ImMucin(TM) Pharmaceutical Investing
OncoSec Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference Life Science Investing
